Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9637797
SERIAL NO

14378285

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRa1 CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BEIJING INSTITUTE FOR CANCER RESEARCH100142 FU CHENG ROAD BEIJING HAIDIAN DISTRICT NO 52 BEIJING CITY BEIJING CITY 100142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deng, Dajun Beijing, CN 5 3
Gu, Liankun Beijing, CN 2 2
Liu, Zhaojun Beijing, CN 18 499
Zhang, Baozhen Beijing, CN 2 2
Zhang, Jun Beijing, CN 1152 7034
Zhou, Jing Beijing, CN 231 2106

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00